LEO partners to reduce multi-hour dermatology treatments to seconds
LEO and Elektrofi begin development of injectable dermatological drugs to replace infusions, reducing the amount of time required for treatment.
Archives for April 11, 2019
Selexis’ biologic platform generates first-ever approved Soliris biosimilar
First-ever Soliris biosimilar approved in Russia after it was produced through Selexis’ SureTechnology platform and cell line.
Manufacturing and the microbiome: Lonza, Chr. Hansen set out to pioneer the live biotherapeutic products industry
Bringing together the food industry’s know-how and pharma’s manufacturing expertise, the new joint venture from Lonza and Chr. Hansen is positioned to pioneer the live biotherapeutic products space – addressing medical needs not met with ‘conventional’...